Multiplicom’s multiplex PCR technology (an algorithm for the design of multiplex PCR primers called MultiplexerTM ) and our expertise are based on years of wet-lab experiments that proved the validity of our approach and resulted in a number of applications: Multiplex Amplicon Quantification (MAQ) Multiplex PCR based 454 sequencing Multiplex based microsatellite genotyping Every application benefits fully from the advantages of multiplex PCR: a large reduction in time and costs compared to standard PCR methods and other molecular approaches.
A simple, robust and complete CE-IVD validated diagnostic test of breast and ovarian related cancer for detection in MPS The BRCA MASTR™ Dx is a molecular diagnostic assay for the identification of mutations in the coding regions of the BRCA 1&2 genes in individuals with increased risk for breast, ovarian and/or related cancers.Multiplicom’s BRCA MASTR™ Dx is ready to use and offers robust performance with minimum hands-on ti…
